A new explanation for why some people are in long-term pain says it could be caused by the immune system attacking the person ...

The Pain Management Unit at Quirónsalud Torrevieja Hospital highlights the need to improve healthcare for patients living ...

An online positive affect program improved mood, reduced pain and fatigue, and boosted response to daily positives in adults ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Fibromyalgia can take years to diagnose, and many healthcare providers still lack the tools to confidently identify it. This ...

Toss in beans: Black beans, edamame and kidney beans are all good sources of magnesium. Snack on some Edamame with Aleppo Pepper, add beans to tostadas, fajitas or burrito bowls or whip up a big batch ...

FDA concluded that AXS-14’s New Drug Application was not sufficiently complete for substantive review, citing concerns with one of two clinical trials in fibromyalgia patients.

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

Shan critiqued several factors of the study, including use of Patient Global Impression of Change (PGIC) for the primary endpoint, the statistical analysis, the control group selection, and ...

It's heart-warming every time to see the relief and a smile on someone's face, knowing that others understand what they are ...

SINGAPORE – Madam Jane Chua used to be a physically active person who enjoyed cycling, running and swimming, often completing up to 20 laps at a time with ease. But more than a decade ago, her ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...